
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.300 | 0.820 | 0.520 |
Stocks | 99.700 | 99.700 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.267 | 17.868 |
Price to Book | 2.993 | 3.667 |
Price to Sales | 2.718 | 5.366 |
Price to Cash Flow | 13.705 | 13.597 |
Dividend Yield | 1.201 | 0.512 |
5 Years Earnings Growth | 6.316 | 19.402 |
Number of long holdings: 97
Number of short holdings: 25
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Gilead | US3755581036 | 3.55 | 114.43 | -2.37% | |
Vericel Corp Ord | US92346J1088 | 3.55 | 47.81 | -2.13% | |
Bio-Techne | US09073M1045 | 3.38 | 58.47 | -7.04% | |
Novartis | CH0012005267 | 3.32 | 95.70 | -5.60% | |
PTC Therapeutics | US69366J2006 | 3.31 | 52.59 | +0.19% | |
Alnylam | US02043Q1076 | 3.25 | 238.74 | +2.43% | |
Bristol-Myers Squibb | US1101221083 | 3.15 | 61.51 | -2.54% | |
Lonza Group | CH0013841017 | 3.12 | 534.00 | -1.87% | |
Vertex | US92532F1003 | 3.01 | 488.34 | -2.33% | |
Arcellx Inc | - | 3.00 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JPI Global Income Fund A mth USD he | 17.27B | 1.98 | 2.67 | 3.89 | ||
JPI Global Income Fund C acc USD he | 17.27B | 2.03 | 3.37 | 4.60 | ||
JPI Global Income Fund C dist USD h | 17.27B | 2.03 | 3.36 | 4.59 | ||
JPI Global Income Fund C mth USD he | 17.27B | 2.03 | 3.37 | 4.59 | ||
JPI Global Income Fund D acc USD he | 17.27B | 1.95 | 2.33 | 3.55 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review